Laboratory Corp. of America Holdings (NYSE:LH) came in second among Visium’s holdings with the firm owning 3.24 million shares valued at $408.82 million. Like several other stocks in the healthcare sector, it is expected to perform better in the second quarter of 2015, with predicted earnings per share of $2.03 after a first quarter in which it earned $1.73 per share. The stock was recently raised to a “Buy” rating from a “Hold” by analysts at Zacks, which has a price target of $135.00 on the stock. Analysts at JPMorgan raised their price target on the stock to $144.00 from $141.00 and issued an “Overweight” rating on the stock. Several other analysts have also either raised their price targets or upgraded their ratings on the stock. This is good news for individuals and organizations that have invested in Laboratory Corp. of America Holdings (NYSE:LH), which include Roberto Mignone‘s Bridger Management, March Altus Capital Management, and Healthcor Management LP.
Perrigo Company PLC Ordinary Shares (NYSE:PRGO) has become the third-largest holding of Visium Asset Management as of March 31. with the firm holding a total of 2.00 million shares valued at $330.86 million. The first quarter of 2015 saw the company post $1.85 in earnings per share, trouncing analysts’ consensus estimate of $1.78. That also easily beat the $1.31 in earnings per share registered by Perrigo Company PLC Ordinary Shares (NYSE:PRGO) in the same quarter last year. The total revenue of the company however came in slightly below analysts’ estimates at $1.05 billion against the $1.10 billion predicted. Thirteen brokerages that are currently covering the stock have given it a consensus rating of “Hold.” The average target price for the next twelve months among brokerages is $200 according to estimates issued within the past year, indicating limited potential upside of 5%. Discussions are currently underway for Mylan NV to purchase the company, although no deal has been finalized. After Perrigo Company PLC Ordinary Shares (NYSE:PRGO) rejected an offer by Mylan last month, the latter company plans to launch a hostile takeover bid that will let the shareholders of the former decide its fate. Among those shareholders of Perrigo’s stock are Pennant Capital Management, Highfields Capital Management, and Nancy Havens-Hasty‘s Havens Advisors.